Topics

Articles

Five-year deal covers manufacturing of molecules, ranging from monoclonal antibodies to antibody-drug conjugates

Lonza and Bioqube sign biologics agreement

Subject to regulatory approval, CDMO will produce mRNA vaccine on a commercial scale

GreenLight Biosciences, Samsung Biologics partner up to develop Covid vaccine candidate 

The Discovery Centre will be powered by AI technology, robotics, among other features 

AstraZeneca opens new $1.3 billion R&D plant

Transaction is anticipated to further Novo’s research in the field of RNAi therapeutics

Novo Nordisk inks $3.3 billion deal for Dicerna Pharma

Acquisition of biopharma company features sotatercept, which is in Phase III trials for the treatment of pulmonary arterial hypertension

Merck purchases Acceleron Pharma for $11.5 billion

Financial commitment expected to increase plant's process development and manufacturing capacity

Sterling Pharma Solutions unveils $13.4 million investment plan for Dudley, UK site

Industrialized collaboration is critical to taking next-generation cell and gene therapies to the next level—if companies can build on pandemic-partnering momentum

The Key Force in CGT Commercialization

Separation process expected to be completed in 18-24 months

J&J to branch out its consumer health business

Expansion expected to more than double the plant’s footprint

Fujifilm Irvine Scientific further develops its Armstrong R&D Cell Culture Center of Excellence 

CDMO’s expansion of Hopkinton, MA facility will include seven new ISO 7 cGMP suites

Business and Finance